Drug Trial Radar · NCT00066573
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Last checked: Nov 19, 2026Latest source record: Aug 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,576
Actual
Start
Jun 6, 2003
Primary completion
Nov 7, 2010
Study completion Jan 6, 2012
Sponsor
- Lead sponsor
- NCIC Clinical Trials GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI); North Central Cancer Treatment Group; Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; SWOG Cancer Research Network; ETOP IBCSG Partners Foundation
- First posted
- Aug 7, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy, using exemestane or anastrozole, may fight breast cancer by reducing the production of estrogen. It is not yet known whether exemestane is more effective than anastrozole in preventing the recurrence of breast cancer. PURPOSE: This randomized phase III trial is studying exemestane to see how well it works compared to anastrozole in preventing cancer recurrence in postmenopausal women who have undergone surgery for primary breast cancer.
Conditions
- Breast Cancer
Interventions
anastrozoleDrug
Given orally
exemestaneDrug
Given orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free SurvivalTime frame: 5 years
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Lethbridge Cancer Centre
Lethbridge, Alberta, Canada
BCCA - Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada
Penticton Regional Hospital
Penticton, British Columbia, Canada
BCCA - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
BCCA - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
BCCA - Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
CancerCare Manitoba
Winnipeg, Manitoba, Canada
The Moncton Hospital
Moncton, New Brunswick, Canada
The Vitalite Health Network - Dr. Leon Richard
Moncton, New Brunswick, Canada
Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
Quinte Healthcare Corporation
Belleville, Ontario, Canada
Cambridge Memorial Hospital
Cambridge, Ontario, Canada
Regional Cancer Program of the Hopital Regional
Greater Sudbury, Ontario, Canada
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
Grand River Regional Cancer Centre
Kitchener, Ontario, Canada
London Regional Cancer Program
London, Ontario, Canada
Credit Valley Hospital
Mississauga, Ontario, Canada
Stronach Regional Health Centre at Southlake
Newmarket, Ontario, Canada
Lakeridge Health Oshawa
Oshawa, Ontario, Canada
Algoma District Cancer Program
Sault Ste. Marie, Ontario, Canada
Niagara Health System
St. Catharines, Ontario, Canada
Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
Odette Cancer Centre
Toronto, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
Univ. Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
Trillium Health Centre - West Toronto
Toronto, Ontario, Canada
Windsor Regional Cancer Centre
Windsor, Ontario, Canada
PEI Cancer Treatment Centre,Queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada
Centre de Sante et de services sociaux de Gatineau
Gatineau, Quebec, Canada
Hopital Charles LeMoyne
Greenfield Park, Quebec, Canada
CHUM - Hopital Notre-Dame
Montreal, Quebec, Canada
CHA-Hopital Du St-Sacrement
Québec, Quebec, Canada
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.